Theagene Jean-Manasse 4
4 · MAIA Biotechnology, Inc. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
Theagene Jean-Manasse
Director
Transactions
- Award
Stock Options
2023-12-31+15,418→ 15,418 totalExercise: $1.17From: 2023-12-31Exp: 2033-12-31→ Common Stock (15,418 underlying)
Footnotes (1)
- [F1]The stock options, granted on December 31, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.